As a concluding introduction video ended, Wu Hao opened his hands and announced to everyone:

"This is our intelligent bionic artificial heart!"

Bang bang bang bang...

Immediately, all the guests at the scene stood up and clapped and cheered. In their opinion, this was indeed the most perfect artificial organ created by human beings so far. If all the data is true, this intelligent bionic artificial heart can be applied to some patients, thus saving many lives.

From this point of view, Haoyu Technology’s previous warm-up publicity is not false and exaggerated. This product is enough to benefit all mankind and is enough to be recorded in the history of human medical development.

After waiting for the applause to end, Wu Hao continued to speak to everyone.

"Having introduced so much, I believe everyone is more concerned about whether this intelligent bionic artificial heart has been used in clinical applications and what its effect is."

After hearing his words, everyone at the scene fell silent and stared at Wu Hao on the stage, expecting his answer.

As for Wu Hao, he did not disappoint everyone. He smiled and nodded and said, "Yes, this intelligent bionic artificial heart has been successfully used clinically by us and saved the lives of two patients."

Seeing everyone's expressions of surprise and joy, Wu Hao continued to introduce with a smile: "After our intelligent bionic artificial heart was developed, we immediately started related testing experiments, mainly on experimental animals at the beginning. Through a series of experiments, we found that The performance of this intelligent bionic artificial heart is very good, even surprising.

These are the two experimental macaques we used for testing. They are both from commercial companies that specialize in raising and breeding such experimental animals.

After we installed intelligent bionic artificial hearts on these two macaques, their physiological signs were not affected in any way and returned to normal, just like normal macaques. Now these two macaques have survived for more than 400 days, and all physiological signs of their bodies are still healthy. They are kept in our specialized laboratory and everyone will be able to see them tomorrow.

After completing a series of related experimental projects including animal experiments in the early stage, we immediately began to prepare for clinical trials and recruit relevant experimental subjects, that is, volunteers.

Because the risks of this clinical trial are huge, we are extremely cautious when selecting clinical trial subjects. The patients selected are all patients with severe heart disease. Their heart disease has developed to a very serious stage, and there is no treatment other than heart replacement.

Everyone is aware of the difficulty of heart transplantation. The most difficult thing is not the difficulty of the operation, but the difficulty of matching the heart source. There are so many patients with heart disease, but the number of matching hearts is very limited. It can be said that tens of thousands or even hundreds of thousands of people are competing for a heart.

This is not just about having money and power. You have to consider timing, and more importantly, chance. Many patients end up regretting missing out just because of a slight difference.

The clinical trial subjects we come into contact with are this type of patients. For them, this is undoubtedly a hope and opportunity that can restore their lives. Although the risk is high, at this stage they have nothing to consider.

If you undergo a clinical trial, the operation may fail and you may die directly. If you give up this opportunity, you can only wait for the elusive heart transplant opportunity, and then die slowly.

Therefore, most of the patients we contact are willing to take the risk, and therefore, we receive many clinical trial applications.

We then begin screening these clinical trial applications to select a number of eligible patients. Because it is a phase I clinical trial, we are extremely cautious about this and have repeatedly considered it when choosing clinical trials.

In the end, we selected thirty patients and prepared for further screening, and finally selected several clinical trial patients to officially enter the clinical trial.

But at this moment, two of the patients were suddenly in critical condition. One of the patients had his heart stop beating three times within a day, each time being very dangerous.

According to the doctor's diagnosis, the patient may die at any time if a heart transplant is not performed.

All patients and their families immediately came to us and asked us to immediately perform intelligent bionic artificial heart implantation surgery for the patients.

This is certainly not in compliance with the relevant regulations, but the patient and his family have strong wishes. The patient's daughter is very filial. In order to convince us, she took the initiative to prepare a relevant disclaimer letter and recorded a relevant video to explain the reasons in detail.

In addition, the patient’s daughter also sent relevant emails to me and many colleagues in the company. In order to beg us, she even personally found our scientific research expert in charge of this clinical trial and knelt down directly to plead.

We were all moved by this. We also have parents, and we can naturally understand the panic and sadness of losing a loved one, as well as the longing for the last hope.

Therefore, in the spirit of humanity, we are not willing to watch a life pass away because of some rigid regulations.

Therefore, after rapid consultation with relevant departments, we finally decided to make an exception and perform the first intelligent bionic artificial heart transplant for this patient.

Immediately we started relevant surgical preparations, including further comprehensive physical examination of the patient and assessment of surgical risks. Another step is to invite famous cardiac surgery experts to participate in the entire surgical process.

In addition, look for Shuyuan www.zhaoshuyuan. com We also dispatched a professional technical support team to solve relevant technical problems on-site in the operating room. "

"Because the patient's condition is serious and his life may be in danger at any time, we decided to perform the operation as soon as possible. The patient was very happy to get this clinical trial opportunity. In his words, he thanked us for our efforts regardless of the operation. He joked He has already stepped into the gate of hell with two feet, and someone is dragging him behind him, playing tug-of-war with the Lord of Hell, trying to grab his head."

“After completing the relevant preparations, the patient was immediately pushed into the operating room, and the transplantation of the first intelligent bionic artificial heart officially began.

Doctors need to first remove the patient's severely deformed heart that is riddled with holes, stuffed with various stents, then trim the windows, and then replace it with this smart bionic artificial heart.

Although it was the first smart bionic artificial heart transplant operation, the entire operation process went very smoothly. The entire operation took less than four hours, which can be said to be very fast.

As for the patient, he did not feel any pain. After the operation, he was transferred to the ICU special care unit, and his physical and physiological characteristics were normal. "

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like